Literature DB >> 29759663

Cellular Physiology and Clinical Manifestations of Fascicular Arrhythmias in Normal Hearts.

Raphael K Sung1, Penelope A Boyden2, Melvin Scheinman3.   

Abstract

Fascicular ventricular arrhythmias represent a spectrum of ventricular tachycardias dependent on the specialized conduction system. Although they are more common in structurally abnormal hearts, there is an increasing body of literature describing their role in normal hearts. In this review, the authors present data from both basic and clinical research that explore the current understanding of idiopathic fascicular ventricular arrhythmias. Evaluation of the cellular electrophysiology of the Purkinje cells shows clear evidence of enhanced automaticity and triggered activity as potential mechanisms of arrhythmias. Perhaps more importantly, heterogeneity in conduction system velocity and refractoriness of the left ventricular conduction system in animal models are in line with clinical descriptions of re-entrant fascicular arrhythmias in humans. Further advances in our understanding of the conduction system will help bridge the current gap between basic science and clinical fascicular arrhythmias.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Purkinje cells; cellular physiology; fascicular arrhythmias; ventricular tachycardia

Mesh:

Year:  2017        PMID: 29759663     DOI: 10.1016/j.jacep.2017.07.011

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  3 in total

Review 1.  Purkinje physiology and pathophysiology.

Authors:  Penelope A Boyden
Journal:  J Interv Card Electrophysiol       Date:  2018-07-28       Impact factor: 1.900

Review 2.  Ventricular arrhythmias involving the His-Purkinje system in the structurally abnormal heart.

Authors:  Beixin Julie He; Penelope Boyden; Melvin Scheinman
Journal:  Pacing Clin Electrophysiol       Date:  2018-08-27       Impact factor: 1.976

3.  Feasibility of selective cardiac ventricular electroporation.

Authors:  Alan Sugrue; Vaibhav R Vaidya; Christopher Livia; Deepak Padmanabhan; Anas Abudan; Ameesh Isath; Tyra Witt; Christopher V DeSimone; Paul Stalboerger; Suraj Kapa; Samuel J Asirvatham; Christopher J McLeod
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.